Now Reading
Traitomic raises €20M to accelerate market-ready trait development

Traitomic raises €20M to accelerate market-ready trait development

Traitomic raises €20M to accelerate market-ready trait development

Traitomic, a Danish biotechnology company developing market-ready, non-GE/non-GM traits in plants and microorganisms, has raised €20 million in a Series A round led by Sofinnova Partners. The investor consortium also includes the Export and Investment Fund of Denmark (EIFO), Footprint Firm, Nordic Foodtech VC, PSV Hafnium, and SVG Ventures. The round marks Traitomic’s first external investment since its spin-out from Carlsberg and follows the development of a growing customer base across multiple industries. The funding will support international expansion and continued development of the company’s scientific and commercial capabilities.

The world increasingly depends on improved biological performance to address challenges in food security, resource efficiency, and sustainability. Yet translating a biological need into a commercially relevant trait can be slow, fragmented, and difficult to scale. Traitomic helps bridge that gap not only by developing market-ready traits, but also by supporting customers from initial commercial challenges through to deployment.

Traitomic’s proprietary FIND-IT platform identifies specific genetic variants in conventionally bred populations without gene editing, enabling rapid trait development while maintaining broad regulatory and commercial applicability. Unlike many trait-development approaches that are tailored to specific organism types, the platform can be applied across both plant and microbial systems.

To date, Traitomic has delivered 116 traits to 47 customers across 32 organisms spanning plant breeding and seed; food supply chain and precision nutrition; and biosolutions and industrial biotech. The projects range from improving crop robustness and yield to developing differentiated food products with enhanced flavour, nutrition, or shelf life, and optimising enzymes and strains used in industrial biotechnology. This breadth of applications reflects demand from customers across multiple industries and highlights the significant opportunity to expand trait development across the broader bioeconomy.

See Also
Rift raises €4.6M to build global network for on-demand aerial intelligence

The funding will support Traitomic’s international expansion and help the company capture this opportunity across food, agriculture and biosolutions markets. In addition, Traitomic will continue to broaden its integrated offering, enabling closer collaboration with customers from initial biological or commercial challenges through delivery of market-ready traits.

Startups Magazine. All rights reserved. c 2026. Company number is: 06755141

Scroll To Top